Scottish Biologics Facility

The Kosterlitz Centre for Therapeutics has close links to the Scottish Biologics Facility (SBF), which develops antibodies against novel targets generated from a range of internal and external sources. In order to maximise the impact of disease targets discovered by the KCT, in cases where antibodies can be of value, the SBF will have access to these targets and the two centres will collaborate to generate therapeutic and diagnostic antibodies.